Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I J McFadyen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Design of a high affinity peptidomimetic opioid agonist from peptide pharmacophore modelsC Wang, I J McFadyen, J R Traynor, et al.
Protein Engineering|January 26, 2002
Exploring the unique pharmacology of a novel opioid receptor, ZFOR1, using molecular modeling and the 'message-address' conceptI J McFadyen, T G Metzger, M G Paterlini, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|March 22, 2000
Modifications of the cyclic mu receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]NH2 (Et): effects on opioid receptor binding and activationI J McFadyen, J C Ho, H I Mosberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G proteinA Alt, I J McFadyen, C D Fan, et al.
Molecular Pharmacology|September 22, 2000
The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophoreI J McFadyen, H Houshyar, L Y Liu-Chen, et al.
Breast (Edinburgh, Scotland)|January 21, 2004
A randomized double blind-cross over trial of soya protein for the treatment of cyclical breast painI J McFadyen, U Chetty, K D Setchell, et al.
Neuroscience Letters|July 13, 2000
Characterization of ZFOR1, a putative delta-opioid receptor from the teleost zebrafish (Danio rerio)R E Rodriguez, A Barrallo, F Garcia-Malvar, et al.
Clinical Endocrinology|July 1, 1980
Gonadal-pituitary hormone levels in gynaecomastiaI J McFadyen, A E Bolton, E H Cameron, et al.
Lancet (London, England)|May 22, 1976
Circulating hormone concentrations in women with breast cancerI J McFadyen, A P Forrest, R J Prescott, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Tetrapeptide derivatives of [D-Pen(2),D-Pen(5)]-enkephalin (DPDPE) lacking an N-terminal tyrosine residue are agonists at the mu-opioid receptorI J McFadyen, K Sobczyk-Kojiro, M J Schaefer, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Design of a high affinity peptidomimetic opioid agonist from peptide pharmacophore modelsC Wang, I J McFadyen, J R Traynor, et al.
Protein Engineering|January 26, 2002
Exploring the unique pharmacology of a novel opioid receptor, ZFOR1, using molecular modeling and the 'message-address' conceptI J McFadyen, T G Metzger, M G Paterlini, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|March 22, 2000
Modifications of the cyclic mu receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]NH2 (Et): effects on opioid receptor binding and activationI J McFadyen, J C Ho, H I Mosberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G proteinA Alt, I J McFadyen, C D Fan, et al.
Molecular Pharmacology|September 22, 2000
The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophoreI J McFadyen, H Houshyar, L Y Liu-Chen, et al.
Breast (Edinburgh, Scotland)|January 21, 2004
A randomized double blind-cross over trial of soya protein for the treatment of cyclical breast painI J McFadyen, U Chetty, K D Setchell, et al.
Neuroscience Letters|July 13, 2000
Characterization of ZFOR1, a putative delta-opioid receptor from the teleost zebrafish (Danio rerio)R E Rodriguez, A Barrallo, F Garcia-Malvar, et al.
Clinical Endocrinology|July 1, 1980
Gonadal-pituitary hormone levels in gynaecomastiaI J McFadyen, A E Bolton, E H Cameron, et al.
Lancet (London, England)|May 22, 1976
Circulating hormone concentrations in women with breast cancerI J McFadyen, A P Forrest, R J Prescott, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Tetrapeptide derivatives of [D-Pen(2),D-Pen(5)]-enkephalin (DPDPE) lacking an N-terminal tyrosine residue are agonists at the mu-opioid receptorI J McFadyen, K Sobczyk-Kojiro, M J Schaefer, et al.
Pageof 1